2024
Cardiovascular risk in young people with childhood onset systemic lupus erythematosus. (Journal article)
Ciurtin, C., Robinson, G., Butt, M., Peng, J., Ardoin, S., Schanberg, L., . . . PReS Lupus Working Party and CARRA Lupus Group.. (2024). Cardiovascular risk in young people with childhood onset systemic lupus erythematosus.. The Lancet. Rheumatology, 6(5), e258-e263. doi:10.1016/s2665-9913(24)00085-7DOI: 10.1016/s2665-9913(24)00085-7
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Marks, S. D. (2024). Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.. Clinical immunology (Orlando, Fla.), 110214. doi:10.1016/j.clim.2024.110214DOI: 10.1016/j.clim.2024.110214
Renaudineau, Y., Charras, A., Natoli, V., Fusaro, M., Smith, E. M. D., Beresford, M. W., . . . UK jSLE Cohort Study. (2024). Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.. Clinical immunology (Orlando, Fla.), 262, 110194. doi:10.1016/j.clim.2024.110194DOI: 10.1016/j.clim.2024.110194
2023
Md Yusof, M. Y., Smith, E. M. D., Ainsworth, S., Armon, K., Beresford, M. W., Brown, M., . . . Vital, E. M. (2023). Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.. Rheumatology advances in practice, 7(3), rkad093. doi:10.1093/rap/rkad093DOI: 10.1093/rap/rkad093
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. ANNALS OF THE RHEUMATIC DISEASES, 82(6), 788-798. doi:10.1136/ard-2022-223328DOI: 10.1136/ard-2022-223328
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS) (Journal article)
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). CLINICAL IMMUNOLOGY, 250. doi:10.1016/j.clim.2023.109296DOI: 10.1016/j.clim.2023.109296
Current views on lupus in children (Journal article)
Smith, E. M. D., Lythgoe, H., & Hedrich, C. M. (2023). Current views on lupus in children. CURRENT OPINION IN RHEUMATOLOGY, 35(2), 68-81. doi:10.1097/BOR.0000000000000913DOI: 10.1097/BOR.0000000000000913
Charras, A., Haldenby, S., Smith, E. M. D., Egbivwie, N., Olohan, L., Kenny, J. G., . . . Hedrich, C. M. (2023). Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. RHEUMATOLOGY, 62(SI2), SI210-SI225. doi:10.1093/rheumatology/keac275DOI: 10.1093/rheumatology/keac275
2022
Elliott, R. S., Taylor, E., Ainsworth, J., Preston, J., & Smith, E. M. D. S. (2022). Improving communication of the concept of 'treat-to target' in childhood lupus: a public and patient (PPI) engagement project involving children and young people. BMC RHEUMATOLOGY, 6(1). doi:10.1186/s41927-022-00300-zDOI: 10.1186/s41927-022-00300-z
Singhal, S., Smith, E. M. D., Roper, L., & Pain, C. E. (2022). The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure. BMC RHEUMATOLOGY, 6(1). doi:10.1186/s41927-022-00312-9DOI: 10.1186/s41927-022-00312-9
Smith, E. M. D., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., Brennan, M., . . . Beresford, M. W. (n.d.). Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. Rheumatology. doi:10.1093/rheumatology/keab915DOI: 10.1093/rheumatology/keab915
Smith, E. M. D., Egbivwie, N., Cowan, K., Ramanan, A. V., & Pain, C. E. (2022). Research priority setting for paediatric rheumatology in the UK. LANCET RHEUMATOLOGY, 4(7), E517-E524. doi:10.1016/S2665-9913(22)00106-0DOI: 10.1016/S2665-9913(22)00106-0
Smith, E. M. D., Egbivwie, N., Jorgensen, A. L., Ciurtin, C., Al-Abadi, E., Armon, K., . . . Hedrich, C. M. (2022). Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. CLINICAL IMMUNOLOGY, 239. doi:10.1016/j.clim.2022.109028DOI: 10.1016/j.clim.2022.109028
Gallagher, K. L., Patel, P., Beresford, M. W., & Smith, E. M. D. (2022). What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?. FRONTIERS IN PEDIATRICS, 10. doi:10.3389/fped.2022.884634DOI: 10.3389/fped.2022.884634
Carlsson, E., Quist, A., Davies, J. C., Midgley, A., Smith, E. M. D., Bruce, I. N., . . . Hedrich, C. M. (2022). Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study. Clinical Immunology, 236, 108948. doi:10.1016/j.clim.2022.108948DOI: 10.1016/j.clim.2022.108948
Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland (Journal article)
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Murphy, R., Pilkington, C., Pain, C. E., & Beresford, M. W. (2022). Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. RHEUMATOLOGY. doi:10.1093/rheumatology/keac064DOI: 10.1093/rheumatology/keac064
Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus (Conference Paper)
Sadun, R., Lewandowski, L., Belot, A., Smith, E., & Cooper, J. (2022). Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 2713-2715). Retrieved from https://www.webofscience.com/
2021
Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply (Journal article)
Smith, E. M. D., Beresford, M. W., McCann, L., & Hedrich, C. M. (2022). Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply. RHEUMATOLOGY, 61(1), E27-E28. doi:10.1093/rheumatology/keab667DOI: 10.1093/rheumatology/keab667
Smith, E. M. D., Gorst, S. L., Al-Abadi, E., Hawley, D. P., Leone, V., Pilkington, C., . . . Young, B. (n.d.). “It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE. Rheumatology. doi:10.1093/rheumatology/keab173DOI: 10.1093/rheumatology/keab173
808 Prospective UK and Ireland population-based study of juvenile-onset systemic lupus erythematosus (Conference Paper)
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Pilkington, C., Murphy, R., Pain, C. E., & Beresford, M. W. (2021). 808 Prospective UK and Ireland population-based study of juvenile-onset systemic lupus erythematosus. In Abstracts. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2021-rcpch.211DOI: 10.1136/archdischild-2021-rcpch.211
Giani, T., Smith, E. M., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. LUPUS, 30(12), 1955-1965. doi:10.1177/09612033211045050DOI: 10.1177/09612033211045050
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. LUPUS, 30(4), 597-607. doi:10.1177/0961203320984251DOI: 10.1177/0961203320984251
Smith, E. M. D., Rasul, S., Ciurtin, C., Al-Abadi, E., Armon, K., Bailey, K., . . . Hedrich, C. M. (2021). Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. RHEUMATOLOGY, 60(11), 5271-5281. doi:10.1093/rheumatology/keab210DOI: 10.1093/rheumatology/keab210
Charras, A., Smith, E., & Hedrich, C. M. (2021). Systemic Lupus Erythematosus in Children and Young People. CURRENT RHEUMATOLOGY REPORTS, 23(3). doi:10.1007/s11926-021-00985-0DOI: 10.1007/s11926-021-00985-0
2020
Davies, J., Carlsson, E., Midgley, A., Smith, E., Bruce, I., Beresford, M., & Hedrich, C. (2020). A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment. ARTHRITIS & RHEUMATOLOGY, 72. Retrieved from http://gateway.webofknowledge.com/
Smith, E. M. D., Ainsworth, S., Beresford, M. W., Buys, V., Costello, W., Egert, Y., . . . Stones, S. R. (2020). Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019. PEDIATRIC RHEUMATOLOGY, 18(1). doi:10.1186/s12969-020-00465-2DOI: 10.1186/s12969-020-00465-2
Najm, A., Kostine, M., Pauling, J. D., Ferreira, A. C., Stevens, K., Smith, E., . . . Sepriano, A. (2020). Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations. RMD OPEN, 6(2). doi:10.1136/rmdopen-2020-001398DOI: 10.1136/rmdopen-2020-001398
Stones, S., Smith, E., Ainsworth, S., Buys, V., Costello, W., Egert, Y., . . . Scott, C. (2020). WORLD YOUNG RHEUMATIC DISEASES (WORD) DAY: THE FIRST INTERNATIONAL AWARENESS DAY FOR PAEDIATRIC RHEUMATIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 163). doi:10.1136/annrheumdis-2020-eular.1794DOI: 10.1136/annrheumdis-2020-eular.1794
Massias, J., Smith, E., Beresford, M., & Hedrich, C. (2020). Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 95-96). Retrieved from https://www.webofscience.com/
Campanilho-Marques, R., Deakin, C. T., Simou, S., Papadopoulou, C., Wedderburn, L. R., Pilkington, C. A., & Juvenile Dermatomyositis Research Group (JDRG). (2020). Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients.. Arthritis research & therapy, 22(1), 79. doi:10.1186/s13075-020-02164-5DOI: 10.1186/s13075-020-02164-5
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2020). Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. LUPUS, 29(5), 474-481. doi:10.1177/0961203320909156DOI: 10.1177/0961203320909156
Belot, A., Rice, G. I., Omarjee, S. O., Rouchon, Q., Smith, E. M. D., Moreews, M., . . . Wood, F. (2020). Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2(2), e99-e109. doi:10.1016/s2665-9913(19)30142-0DOI: 10.1016/s2665-9913(19)30142-0
Giani, T., Smith, E., Cimaz, R., Beresford, M., & Hedrich, C. (2020). Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 72. Retrieved from https://www.webofscience.com/
Close, R., Lant, A., Smith, E., Anderson, C. M., Deepak, S., Foster, R., . . . McErlane, F. (2020). SJOGREN'S SYNDROME: A RETROSPECTIVE SERVICE EVALUATION OF DIAGNOSIS AND MANAGEMENT IN PAEDIATRIC PATIENTS. In RHEUMATOLOGY Vol. 59. Retrieved from https://www.webofscience.com/
2019
Smith, E. M. D., Lythgoe, H., Midgley, A., Beresford, M. W., & Hedrich, C. M. (2019). Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. CLINICAL IMMUNOLOGY, 209. doi:10.1016/j.clim.2019.108274DOI: 10.1016/j.clim.2019.108274
Smith, E. M. D., Sen, E. S., & Pain, C. E. (2019). Diagnosis and treatment of childhood-onset systemic lupus erythematosus (European evidence-based recommendations from the SHARE initiative).. Archives of disease in childhood. Education and practice edition, 104(5), 259-264. doi:10.1136/archdischild-2017-314049DOI: 10.1136/archdischild-2017-314049
Lythgoe, H., Pain, C., Smith, E., & Beresford, M. (2019). DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1329). doi:10.1136/annrheumdis-2019-eular.1587DOI: 10.1136/annrheumdis-2019-eular.1587
Smith, E. M., Lythgoe, H., & Hedrich, C. M. (2019). Vasculitis in juvenile-onset systemic lupus erythematosus. Frontiers in Pediatrics, 7(APR). doi:10.3389/fped.2019.00149DOI: 10.3389/fped.2019.00149
Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Hedrich, C. M. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.. Lupus, 961203319836712. doi:10.1177/0961203319836712DOI: 10.1177/0961203319836712
Smith, E. M. D., Eleuteri, A., Goilav, B., Lewandowski, L., Phuti, A., Rubinstein, T., . . . Beresford, M. W. (2019). A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. CLINICAL IMMUNOLOGY, 198, 71-78. doi:10.1016/j.clim.2018.10.021DOI: 10.1016/j.clim.2018.10.021
Egert, Y., Egert, T., Costello, W., Prakken, B. J., Smith, E. M. D., & Wulffraat, N. M. (2019). Children and young people get rheumatic disease too.. The Lancet. Child & adolescent health, 3(1), 8-9. doi:10.1016/s2352-4642(18)30374-2DOI: 10.1016/s2352-4642(18)30374-2
2018
Foster, H. E., Vojinovic, J., Constantin, T., Martini, A., Dolezalova, P., Uziel, Y., . . . Wulffraat, N. (2018). Educational initiatives and training for paediatric rheumatology in Europe. PEDIATRIC RHEUMATOLOGY, 16. doi:10.1186/s12969-018-0289-yDOI: 10.1186/s12969-018-0289-y
Smith, E. M. D., Lewandowski, L. B., Jorgensen, A. L., Phuti, A., Nourse, P., Scott, C., & Beresford, M. W. (2018). Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27(14), 2190-2199. doi:10.1177/0961203318808376DOI: 10.1177/0961203318808376
Smith, E. M. D., Yin, P., Jorgensen, A. L., & Beresford, M. W. (2018). Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27(13), 2020-2028. doi:10.1177/0961203318801526DOI: 10.1177/0961203318801526
Kostine, M., Najm, A., Pauling, J., Ferreira, A. C., Stevens, K., Smith, E., . . . Richez, C. (2018). MULTIDISCIPLINARY COLLABORATION AMONG YOUNG SPECIALISTS: RESULTS OF AN ONGOING INTERNATIONAL SURVEY BY YOUNG ORGANISATIONS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 198-199). doi:10.1136/annrheumdis-2018-eular.7004DOI: 10.1136/annrheumdis-2018-eular.7004
Deakin, C. T., Campanilho-Marques, R., Simou, S., Moraitis, E., Wedderburn, L. R., Pullenayegum, E., . . . Juvenile Dermatomyositis Research Group. (2018). Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.. Arthritis & rheumatology (Hoboken, N.J.), 70(5), 785-793. doi:10.1002/art.40418DOI: 10.1002/art.40418
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2018). Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Practice and Research: Clinical Rheumatology. doi:10.1016/j.berh.2018.02.001DOI: 10.1016/j.berh.2018.02.001
Smith, E. M. D., Yin, P., Jorgensen, A., & Beresford, M. (2018). Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study. Pediatric Rheumatology Online Journal, 16(1). doi:10.1186/s12969-018-0230-4DOI: 10.1186/s12969-018-0230-4
2017
USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS (Conference Paper)
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. W. (2017). USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS. In RHEUMATOLOGY Vol. 56 (pp. 19-20). Retrieved from https://www.webofscience.com/
Smith, E. M. D., & Beresford, M. W. (2017). Urinary biomarkers in childhood lupus nephritis. CLINICAL IMMUNOLOGY, 185, 21-31. doi:10.1016/j.clim.2016.06.010DOI: 10.1016/j.clim.2016.06.010
Developing an Education Resource for the paediatric BILAG index (Conference Paper)
Richards, E., Poutney, M., Holt, A., Prescott, D., Smith, E., Roberts, C., & Beresford, M. (2017). Developing an Education Resource for the paediatric BILAG index. In RHEUMATOLOGY Vol. 56. doi:10.1093/rheumatology/kex356.019DOI: 10.1093/rheumatology/kex356.019
Smith, E. M. D., Jorgensen, A. L., & Beresford, M. W. (2017). Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.. Lupus, 26(11), 1212-1217. doi:10.1177/0961203317702253DOI: 10.1177/0961203317702253
Smith, E. M. D., Jorgensen, A. L., Midgley, A., Oni, L., Goilav, B., Putterman, C., . . . Beresford, M. W. (2017). International validation of a urinary biomarker panel for identification of active lupus nephritis in children.. Pediatric Nephrology, 32(2), 283-295. doi:10.1007/s00467-016-3485-3DOI: 10.1007/s00467-016-3485-3
DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH (Conference Paper)
Lythgoe, H., Smith, E., Pain, C., Murphy, R., Killeen, O., Pilkington, C., & Beresford, M. W. (2017). DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH. In RHEUMATOLOGY Vol. 56 (pp. 3-+). Retrieved from https://www.webofscience.com/
LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES (Conference Paper)
Wilson, E., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
2016
Deakin, C. T., Yasin, S. A., Simou, S., Arnold, K. A., Tansley, S. L., Betteridge, Z. E., . . . UK Juvenile Dermatomyositis Research Group. (2016). Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.. Arthritis & rheumatology (Hoboken, N.J.), 68(11), 2806-2816. doi:10.1002/art.39753DOI: 10.1002/art.39753
Campanilho-Marques, R., Almeida, B., Deakin, C., Arnold, K., Gallot, N., de Iorio, M., . . . Juvenile Dermatomyositis Research Group. (2016). Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.. Arthritis care & research, 68(10), 1514-1521. doi:10.1002/acr.22867DOI: 10.1002/acr.22867
Smith, E. M. D. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial.
Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION) (Thesis / Dissertation)
Smith, E. M. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION).
Patel, M., Oni, L., Midgley, A., Smith, E., Tullus, K., Marks, S. D., . . . Beresford, M. W. (2016). Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25(9), 1040-1044. doi:10.1177/0961203316631634DOI: 10.1177/0961203316631634
EXPERIENCES FROM YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY (Conference Paper)
Smith, E. (2016). EXPERIENCES FROM YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 15). doi:10.1136/annrheumdis-2016-eular.6424DOI: 10.1136/annrheumdis-2016-eular.6424
Thorbinson, C., Oni, L., Smith, E., Midgley, A., & Beresford, M. W. (2016). Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. PEDIATRIC DRUGS, 18(3), 181-195. doi:10.1007/s40272-016-0170-8DOI: 10.1007/s40272-016-0170-8
2015
DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY (Conference Paper)
Smith, E. M. D., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S. D., . . . Beresford, M. W. (2015). DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY. In RHEUMATOLOGY Vol. 54 (pp. 3). doi:10.1093/rheumatology/keu492DOI: 10.1093/rheumatology/keu492
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2015). The development and assessment of biological treatments for children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 379-394. doi:10.1111/bcp.12406DOI: 10.1111/bcp.12406
AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN (Conference Paper)
Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv153.5DOI: 10.1093/ndt/gfv153.5
2014
INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS (Conference Paper)
Smith, E. M. D., Watson, L., Jones, C., Pilkington, C. A., Marks, S. D., Tullus, K., & Beresford, M. W. (2014). INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. RHEUMATOLOGY, 53(3), 557-561. doi:10.1093/rheumatology/ket402DOI: 10.1093/rheumatology/ket402
2013
Smith, E. M. D., & Ramanan, A. V. (2013). Fifteen-minute consultation: A structured approach to the management of hypermobility in a child.. Archives of disease in childhood. Education and practice edition, 98(6), 212-216. doi:10.1136/archdischild-2013-303882DOI: 10.1136/archdischild-2013-303882
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2013). Adding to complexity: comorbidity in paediatric rheumatic disease. RHEUMATOLOGY, 52(1), 22-33. doi:10.1093/rheumatology/kes256DOI: 10.1093/rheumatology/kes256
2012
Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children. (Journal article)
Smith, E., Molyneux, E., Heikens, G. T., & Foster, H. (2012). Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children.. Clinical rheumatology, 31(4), 647-653. doi:10.1007/s10067-011-1901-4DOI: 10.1007/s10067-011-1901-4
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY (Conference Paper)
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY (Conference Paper)
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
Smith, E., Anderson, M., & Foster, H. (2012). The child with a limp: a symptom and not a diagnosis.. Archives of disease in childhood. Education and practice edition, 97(5), 185-193. doi:10.1136/archdischild-2011-301245DOI: 10.1136/archdischild-2011-301245
2010
Smith, E., Kumar, R., Barron, R., & Bosman, D. (2010). An unusual cause of neonatal respiratory distress.. BMJ case reports, 2010, bcr0520103022. doi:10.1136/bcr.05.2010.3022DOI: 10.1136/bcr.05.2010.3022
2006
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude. (Journal article)
Smith, E. M. D., Baillie, J. K., Thompson, A. A. R., Irving, J. B., Porteous, D., & Webb, D. J. (2006). Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude.. High altitude medicine & biology, 7(3), 221-227. doi:10.1089/ham.2006.7.221DOI: 10.1089/ham.2006.7.221